Regeneron genetics center discovers gpr75 gene mutations that protect against obesity

Tarrytown, n.y., july 1, 2021 /prnewswire/ -- publication in science reports that people with these protective mutations have 54% reduced risk of obesity regeneron used its velocigene® technology to create mice with similar protective mutation that are resistant to obesity regeneron already creating potential therapeutics to fight obesity using its velocimmune® technology and collaborator alnylam's sirna technology regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that scientists from the regeneron genetics center® (rgc) have discovered rare genetic mutations in the gpr75 gene associated with protection against obesity.
REGN Ratings Summary
REGN Quant Ranking